Copyright © 2010 Jose Irazuzta and Kevin J. Sullivan. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. W. J. Molofsky, “Managing stroke in children,” Pediatric Annals, vol. 35, no. 5, pp. 379–384, 2006. View at Scopus
2. E. S. Roach, M. R. Golomb, and M. R. Golomb, “Management of stroke in infants and children: a scientific statement from a special writing group of the american heart association stroke council and the council on cardiovascular disease in the young,” Stroke, vol. 39, no. 9, pp. 2644–2691, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
3. J. F. Maestre-Moreno, M. D. Fernández-Pérez, C. Arnáiz-Urrutia, A. Mínguez, P. Navarrete-Navarro, and J. Martínez-Bosch, “Thrombolysis in stroke: inappropriate consideration of the 'window period' as the time available,” Revista de Neurologia, vol. 40, no. 5, pp. 274–278, 2005. View at Scopus
4. H. P. Adams Jr., G. del Zoppo, and M. J. Alberts, “Guidelines for the early management of adults with ischemic stroke: a guideline from the american heart association/american stroke association stroke council, clinical cardiology council, cardiovascular radiology and intervention council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups: the american academy of neurology affirms the value of this guideline as an educational tool for neurologists,” Circulation, vol. 115, pp. e478–e534, 2007.
5. R. L. Sacco, R. Adams, and R. Adams, “Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke—co-sponsored by the Council on Cardiovascular Radiology and Intervention. The American Academy of Neurology affirms the value of this guideline,” Circulation, vol. 113, no. 10, pp. e409–e449, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
6. W. Hacke, M. Kaste, and M. Kaste, “Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke,” The New England Journal of Medicine, vol. 359, no. 13, pp. 1317–1329, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
7. S. Lanthier, L. Carmant, M. David, A. Larbrisseau, and G. de Veber, “Stroke in children: the coexistence of multiple risk factors predicts poor outcome,” Neurology, vol. 54, no. 2, pp. 371–378, 2000. View at Scopus
8. G. DeVeber, E. Steve Roach, A. R. Riela, and M. Wiznitzer, “Stroke in children: recognition, treatment, and future directions,” Seminars in Pediatric Neurology, vol. 7, no. 4, pp. 309–317, 2000. View at Scopus
9. P. Monagle, A. Chan, P. Massicotte, E. Chalmers, and A. D. Michelson, “Antithrombotic therapy in children: the seventh ACCP conference on antithrombotic and thrombolytic therapy,” Chest, vol. 126, no. 3, pp. 645S–687S, 2004. View at Publisher · View at Google Scholar · View at Scopus
10. Royal College of Physicians PSWG, “Stroke in childhood: clinical guidelines for diagnosis, management, and rehabilitation,” 2004, http://www.rcplondon.ac.uk/pubs/books/childstroke/.
11. G. A. Ortiz, S. Koch, D. M. Wallace, and R. Lopez-Alberola, “Successful intravenous thrombolysis for acute stroke in a child,” Journal of Child Neurology, vol. 22, no. 6, pp. 749–752, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
12. S. L. Benedict, O. K. Ni, P. Schloesser, K. S. White, and J. F. Bale, “Intra-arterial thrombolysis in a 2-year-old with cardioembolic stroke,” Journal of Child Neurology, vol. 22, no. 2, pp. 225–227, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
13. M. D. Carlson, S. Leber, J. Deveikis, and F. S. Silverstein, “Successful use of rt-PA in pediatric stroke,” Neurology, vol. 57, no. 1, pp. 157–158, 2001. View at Scopus
14. M. R. Golomb, M. Rafay, D. Armstrong, P. Massicotte, R. Curtis, S. Hune, and G. A. deVeber, “Intra-arterial tissue plasminogen activator for thrombosis complicating cerebral angiography in a 17-year-old girl,” Journal of Child Neurology, vol. 18, no. 6, pp. 420–423, 2003. View at Scopus
15. E. A. Noser, R. A. Felberg, and A. V. Alexandrov, “Thrombolytic therapy in an adolescent ischemic stroke,” Journal of Child Neurology, vol. 16, no. 4, pp. 286–288, 2001. View at Scopus
16. B. C. Cannon, N. J. Kertesz, R. A. Friedman, and A. L. Fenrich, “Use of tissue plasminogen activator in a stroke after radiofrequency ablation of a left-sided accessory pathway,” Journal of Cardiovascular Electrophysiology, vol. 12, no. 6, pp. 723–725, 2001. View at Scopus
17. C. Amlie-Lefond, G. deVeber, and G. deVeber, “Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study,” The Lancet Neurology, vol. 8, no. 6, pp. 530–536, 2009. View at Publisher · View at Google Scholar · View at Scopus
18. N. Janjua, A. Nasar, J. K. Lynch, and A. I. Qureshi, “Thrombolysis for ischemic stroke in children: data from the nationwide inpatient sample,” Stroke, vol. 38, no. 6, pp. 1850–1854, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
19. G. Thomalla, C. Schwark, and C. Schwark, “Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials,” Stroke, vol. 37, no. 3, pp. 852–858, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
20. A. Furlan, R. Higashida, and R. Higashida, “Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial,” Journal of the American Medical Association, vol. 282, no. 21, pp. 2003–2011, 1999. View at Publisher · View at Google Scholar · View at Scopus
21. A. C. Flint, G. R. Duckwiler, R. F. Budzik, D. S. Liebeskind, and W. S. Smith, “Mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and multi MERCI part I trials,” Stroke, vol. 38, no. 4, pp. 1274–1280, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
22. N. A. Goldenberg, W. E. Hathaway, L. Jacobson, K. Mcfarland, and M. J. Manco-Johnson, “Influence of factor VIII on overall coagulability and fibrinolytic potential of haemophilic plasma as measured by global assay: monitoring in haemophilia A,” Haemophilia, vol. 12, no. 6, pp. 605–614, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
23. A. A. Smith, L. J. Jacobson, B. I. Miller, W. E. Hathaway, and M. J. Manco-Johnson, “A new euglobulin clot lysis assay for global fibrinolysis,” Thrombosis Research, vol. 112, no. 5-6, pp. 329–337, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
24. E. C. Bourekas, A. P. Slivka, and M. J. Casavant, “Intra-arterial thrombolysis of a distal internal carotid artery occlusion in an adolescent,” Neurocritical Care, vol. 2, no. 2, pp. 179–182, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
25. A. Sungarian and J. A. Duncan III, “Vertebrobasilar thrombosis in children: report of two cases and recommendations for treatment,” Pediatric Neurosurgery, vol. 38, no. 1, pp. 16–20, 2003. View at Publisher · View at Google Scholar · View at Scopus
26. M. Arnold, M. Steinlin, and M. Steinlin, “Thrombolysis in childhood stroke report of 2 cases and review of the literature,” Stroke, vol. 40, no. 3, pp. 801–807, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
27. M. I. Shuayto, J. I. Lopez, and F. Greiner, “Administration of intravenous tissue plasminogen activator in a pediatric patient with acute ischemic stroke,” Journal of Child Neurology, vol. 21, no. 7, pp. 604–606, 2006. View at Publisher · View at Google Scholar · View at Scopus
28. R. S. Prasad, L. A. Michaels, S. Roychowdhury, V. Craig, A. Sorrell, and S. Schonfeld, “Combined venous sinus angioplasty and low-dose thrombolytic therapy for treatment of hemorrhagic transverse sinus thrombosis in a pediatric patient,” Journal of Pediatric Hematology/Oncology, vol. 28, no. 3, pp. 196–199, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
29. A. Kirton, J. H. Wong, J. Mah, B. C. Ross, J. Kennedy, K. Bell, and M. D. Hill, “Successful endovascular therapy for acute basilar thrombosis in an adolescent,” Pediatrics, vol. 112, no. 3, part 1, pp. e248–e251, 2003.
30. R. M. Sugg, J. K. Pary, and J. K. Pary, “Argatroban tPA stroke study: study design and results in the first treated cohort,” Archives of Neurology, vol. 63, no. 8, pp. 1057–1062, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
31. D. G. Sherman, R. P. Atkinson, and R. P. Atkinson, “Intravenous ancrod for treatment of acute ischemic stroke. The STAT study: a randomized controlled trial,” Journal of the American Medical Association, vol. 283, no. 18, pp. 2395–2403, 2000. View at Scopus
32. The Ancrod Stroke Study Investigators, “Ancrod for the treatment of acute ischemic brain infarction,” Stroke, vol. 25, no. 9, pp. 1755–1759, 1994. View at Scopus
33. A. J. Furlan, D. Eyding, and D. Eyding, “Dose escalation of desmoteplase for acute ischemic stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset,” Stroke, vol. 37, no. 5, pp. 1227–1231, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
34. W. Hacke, G. Albers, and G. Albers, “The desmoteplase in acute ischemic stroke trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase,” Stroke, vol. 36, no. 1, pp. 66–73, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
35. H. P. Adams Jr., M. B. Effron, and M. B. Effron, “Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: abciximab in emergency treatment of stroke trial (AbESTT-II),” Stroke, vol. 39, no. 1, pp. 87–99, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
36. M. D. Ginsberg and R. Busto, “Combating hyperthermia in acute stroke: a significant clinical concern,” Stroke, vol. 29, no. 2, pp. 529–534, 1998. View at Scopus
37. S. E. Kasner, A. M. Demchuk, and A. M. Demchuk, “Predictors of fatal brain edema in massive hemispheric ischemic stroke,” Stroke, vol. 32, no. 9, pp. 2117–2123, 2001. View at Scopus
38. A. Terent, G. Ronquist, K. Bergstrom, R. Hallgren, and H. Aberg, “Ischemic edema in stroke. A parallel study with computed tomography and cerebrospinal fluid markers of disturbed brain cell metabolism,” Stroke, vol. 12, no. 1, pp. 33–40, 1981.
39. K. Z. Guluma, H. Oh, S.-W. Yu, B. C. Meyer, K. Rapp, and P. D. Lyden, “Effect of endovascular hypothermia on acute ischemic edema: morphometric analysis of the ICTuS trial,” Neurocritical Care, vol. 8, no. 1, pp. 42–47, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
40. H. M. Den Hertog, H. B. van der Worp, M.-C. Tseng, and D. W. J. Dippel, “Cooling therapy for acute stroke,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD001247, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
41. M. S. Damian and R. Schlosser, “Bilateral near infrared spectroscopy in space-occupying middle cerebral artery stroke,” Neurocritical Care, vol. 6, no. 3, pp. 165–173, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
42. Y. Y. Palesch, M. D. Hill, K. J. Ryckborst, D. Tamariz, and M. D. Ginsberg, “The ALIAS Pilot Trial. A dose-escalation and safety study of albumin therapy for acute ischemic stroke—II: neurologic outcome and efficacy analysis,” Stroke, vol. 37, no. 8, pp. 2107–2114, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
43. M. D. Ginsberg, M. D. Hill, Y. Y. Palesch, K. J. Ryckborst, and D. Tamariz, “The ALIAS pilot trial. A dose-escalation and safety study of albumin therapy for acute ischemic stroke—I: physiological responses and safety results,” Stroke, vol. 37, no. 8, pp. 2100–2106, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
44. L. Belayev, Y. Liu, W. Zhao, R. Busto, and M. D. Ginsberg, “Human albumin therapy of acute ischemic stroke: marked neuroprotective efficacy at moderate doses and with a broad therapeutic window,” Stroke, vol. 32, no. 2, pp. 553–560, 2001. View at Scopus
45. J. E. Schnitzer, A. Sung, R. Horvat, and J. Bravo, “Preferential interaction of albumin-binding proteins, gp30 and gp18, with conformationally modified albumins. Presence in many cells and tissues with a possible role in catabolism,” Journal of Biological Chemistry, vol. 267, no. 34, pp. 24544–24553, 1992. View at Scopus
46. P. He and F. E. Curry, “Albumin modulation of capillary permeability: role of endothelial cell [${\text{Ca}}^{2+}$](i),” American Journal of Physiology, vol. 265, no. 1, pp. H74–H82, 1993. View at Scopus
47. L. Ghitescu, A. Fixman, M. Simionescu, and N. Simionescu, “Specific binding sites for albumin restricted to plasmalemmal vesicles of continuous capillary endothelium: receptor-mediated transcytosis,” Journal of Cell Biology, vol. 102, no. 4, pp. 1304–1311, 1986. View at Scopus
48. J. E. Schnitzer, “Gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis,” American Journal of Physiology, vol. 262, no. 1, pp. H246–H254, 1992. View at Scopus
49. J. E. Schnitzer and P. Oh, “Antibodies to SPARC inhibit albumin binding to SPARC, gp60, and microvascular endothelium,” American Journal of Physiology, vol. 263, no. 6, pp. H1872–H1879, 1992. View at Scopus
50. W. H. Reinhart and C. Nagy, “Albumin affects erythrocyte aggregation and sedimentation,” European Journal of Clinical Investigation, vol. 25, no. 7, pp. 523–528, 1995. View at Scopus
51. J. F. Keaney Jr., D. I. Simon, J. S. Stamler, O. Jaraki, J. Scharfstein, J. A. Vita, and J. Loscalzo, “NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties,” Journal of Clinical Investigation, vol. 91, no. 4, pp. 1582–1589, 1993. View at Scopus
52. N. Maalej, R. Albrecht, J. Loscalzo, and J. D. Folts, “The potent platelet inhibitory effects of S-nitrosated albumin coating of artificial surfaces,” Journal of the American College of Cardiology, vol. 33, no. 5, pp. 1408–1414, 1999. View at Publisher · View at Google Scholar · View at Scopus
53. P. W. Huh, L. Belayev, W. Zhao, R. Busto, I. Saul, and M. D. Ginsberg, “The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats,” Brain Research, vol. 804, no. 1, pp. 105–113, 1998. View at Publisher · View at Google Scholar
54. L. Belayev, E. Pinard, and E. Pinard, “Albumin therapy of transient focal cerebral ischemia: in vivo analysis of dynamic microvascular responses,” Stroke, vol. 33, no. 4, pp. 1077–1084, 2002. View at Publisher · View at Google Scholar
55. V. Ramaswamy, V. Mehta, M. Bauman, L. Richer, P. Massicotte, and J. Y. Yager, “Decompressive hemicraniectomy in children with severe ischemic stroke and life-threatening cerebral edema,” Journal of Child Neurology, vol. 23, no. 8, pp. 889–894, 2008. View at Publisher · View at Google Scholar · View at PubMed
56. R. A. Reinhart, “Clinical correlates of the molecular and cellular actions of magnesium on the cardiovascular system,” American Heart Journal, vol. 121, no. 5, pp. 1513–1521, 1991. View at Publisher · View at Google Scholar
57. F. A. X. Schanne, R. K. Gupta, and P. K. Stanton, “31P-NMR study of transient ischemia in rat hippocampal slices in vitro,” Biochimica et Biophysica Acta, vol. 1158, no. 3, pp. 257–263, 1993. View at Publisher · View at Google Scholar
58. B. M. Altura, R. L. Barbour, T. L. Dowd, F. Wu, B. T. Altura, and R. K. Gupta, “Low extracellular magnesium induces intracellular free Mg deficits, ischemia, depletion of high-energy phosphates and cardiac failure in intact working rat hearts: a 31P-NMR study,” Biochimica et Biophysica Acta, vol. 1182, no. 3, pp. 329–332, 1993. View at Publisher · View at Google Scholar
59. L. Nowak, P. Bregestovski, P. Ascher, A. Herbet, and A. Prochiantz, “Magnesium gates glutamate-activated channels in mouse central neurones,” Nature, vol. 307, no. 5950, pp. 462–465, 1984.
60. N. L. Harrison and M. A. Simmonds, “Quantitative studies on some antagonists of N-methyl D-aspartate in slices of rat cerebral cortex,” British Journal of Pharmacology, vol. 84, no. 2, pp. 381–391, 1985.
61. P. K. Stys, B. R. Ransom, and S. G. Waxman, “Effects of polyvalent cations and dihydropyridine calcium channel blockers on recovery of CNS white matter from anoxia,” Neuroscience Letters, vol. 115, no. 2-3, pp. 293–299, 1990. View at Publisher · View at Google Scholar
62. Y. Izumi, S. Roussel, E. Pinard, and J. Seylaz, “Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats,” Journal of Cerebral Blood Flow and Metabolism, vol. 11, no. 6, pp. 1025–1030, 1991.